AAHI: The Access to Advanced Health Institute Receives up to $12.7 Million to Develop Novel NanoAlum Adjuvant Formulation for Better Protection Against Tuberculosis and Pandemic Influenza

The Access to Advanced Health Institute announced that it has been awarded the first stage of funding for a $12.7-million project through the Medical CBRN Defense Consortium Other Transaction Authority to develop a novel immune-stimulating adjuvant formulation that will improve the human immune response to vaccines, providing broader and longer lasting protection against disease.